Patents Assigned to Regentis Biomaterials Ltd.
  • Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
    Patent number: 7842667
    Abstract: A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: November 30, 2010
    Assignee: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany